199 related articles for article (PubMed ID: 27806312)
1. Systematic approach identifies RHOA as a potential biomarker therapeutic target for Asian gastric cancer.
Chang HR; Nam S; Lee J; Kim JH; Jung HR; Park HS; Park S; Ahn YZ; Huh I; Balch C; Ku JL; Powis G; Park T; Jeong JH; Kim YH
Oncotarget; 2016 Dec; 7(49):81435-81451. PubMed ID: 27806312
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-31 inhibits tumor invasion and metastasis by targeting RhoA in human gastric cancer.
Ge F; Wang C; Wang W; Liu W; Wu B
Oncol Rep; 2017 Aug; 38(2):1133-1139. PubMed ID: 28656284
[TBL] [Abstract][Full Text] [Related]
3. Rational design of small molecule RHOA inhibitors for gastric cancer.
Kim JH; Park S; Lim SM; Eom HJ; Balch C; Lee J; Kim GJ; Jeong JH; Nam S; Kim YH
Pharmacogenomics J; 2020 Aug; 20(4):601-612. PubMed ID: 32015453
[TBL] [Abstract][Full Text] [Related]
4. LncRNA CTC-497E21.4 promotes the progression of gastric cancer via modulating miR-22/NET1 axis through RhoA signaling pathway.
Zong W; Feng W; Jiang Y; Cao Y; Ke Y; Shi X; Ju S; Cong H; Wang X; Cui M; Jing R
Gastric Cancer; 2020 Mar; 23(2):228-240. PubMed ID: 31451992
[TBL] [Abstract][Full Text] [Related]
5. A high expression ratio of RhoA/RhoB is associated with the migratory and invasive properties of basal-like Breast Tumors.
Privat M; Cavard A; Zekri Y; Ponelle-Chachuat F; Molnar I; Sonnier N; Bignon YJ
Int J Med Sci; 2020; 17(17):2799-2808. PubMed ID: 33162807
[TBL] [Abstract][Full Text] [Related]
6. Loss of RhoA promotes skin tumor formation and invasion by upregulation of RhoB.
García-Mariscal A; Li H; Pedersen E; Peyrollier K; Ryan KM; Stanley A; Quondamatteo F; Brakebusch C
Oncogene; 2018 Feb; 37(7):847-860. PubMed ID: 29059167
[TBL] [Abstract][Full Text] [Related]
7. HNF4α is a therapeutic target that links AMPK to WNT signalling in early-stage gastric cancer.
Chang HR; Nam S; Kook MC; Kim KT; Liu X; Yao H; Jung HR; Lemos R; Seo HH; Park HS; Gim Y; Hong D; Huh I; Kim YW; Tan D; Liu CG; Powis G; Park T; Liang H; Kim YH
Gut; 2016 Jan; 65(1):19-32. PubMed ID: 25410163
[TBL] [Abstract][Full Text] [Related]
8. c-Met-dependent phosphorylation of RhoA plays a key role in gastric cancer tumorigenesis.
Liu J; Li S; Chen S; Chen S; Geng Q; Xu D
J Pathol; 2019 Sep; 249(1):126-136. PubMed ID: 31056743
[TBL] [Abstract][Full Text] [Related]
9. A novel strategy for specifically down-regulating individual Rho GTPase activity in tumor cells.
Wang L; Yang L; Luo Y; Zheng Y
J Biol Chem; 2003 Nov; 278(45):44617-25. PubMed ID: 12939257
[TBL] [Abstract][Full Text] [Related]
10. Improving gastric cancer preclinical studies using diverse in vitro and in vivo model systems.
Chang HR; Park HS; Ahn YZ; Nam S; Jung HR; Park S; Lee SJ; Balch C; Powis G; Ku JL; Kim YH
BMC Cancer; 2016 Mar; 16():200. PubMed ID: 26955870
[TBL] [Abstract][Full Text] [Related]
11.
Xu C; Ooi WF; Qamra A; Tan J; Chua BY; Ho SWT; Das K; Adam Isa ZF; Li Z; Yao X; Yan T; Xing M; Huang KK; Lin JS; Nandi T; Tay ST; Lee MH; Tan ALK; Ong X; Ashktorab H; Smoot D; Li S; Ng SC; Teh BT; Tan P
Gut; 2020 Feb; 69(2):231-242. PubMed ID: 31068366
[TBL] [Abstract][Full Text] [Related]
12. The Role of RhoA, RhoB and RhoC GTPases in Cell Morphology, Proliferation and Migration in Human Cytomegalovirus (HCMV) Infected Glioblastoma Cells.
Tseliou M; Al-Qahtani A; Alarifi S; Alkahtani SH; Stournaras C; Sourvinos G
Cell Physiol Biochem; 2016; 38(1):94-109. PubMed ID: 26741994
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of Rho-Associated Kinase 1/2 Attenuates Tumor Growth in Murine Gastric Cancer.
Hinsenkamp I; Schulz S; Roscher M; Suhr AM; Meyer B; Munteanu B; Fuchser J; Schoenberg SO; Ebert MP; Wängler B; Hopf C; Burgermeister E
Neoplasia; 2016 Aug; 18(8):500-11. PubMed ID: 27566106
[TBL] [Abstract][Full Text] [Related]
14. Gastrokine 1 inhibits gastric cancer cell migration and invasion by downregulating RhoA expression.
Yoon JH; Choi WS; Kim O; Choi BJ; Nam SW; Lee JY; Park WS
Gastric Cancer; 2017 Mar; 20(2):274-285. PubMed ID: 27250838
[TBL] [Abstract][Full Text] [Related]
15. Rho isoform-specific interaction with IQGAP1 promotes breast cancer cell proliferation and migration.
Casteel DE; Turner S; Schwappacher R; Rangaswami H; Su-Yuo J; Zhuang S; Boss GR; Pilz RB
J Biol Chem; 2012 Nov; 287(45):38367-78. PubMed ID: 22992742
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of Rac GTPase Activating Protein 1 Contributes to Proliferation of Cancer Cells by Reducing Hippo Signaling to Promote Cytokinesis.
Yang XM; Cao XY; He P; Li J; Feng MX; Zhang YL; Zhang XL; Wang YH; Yang Q; Zhu L; Nie HZ; Jiang SH; Tian GA; Zhang XX; Liu Q; Ji J; Zhu X; Xia Q; Zhang ZG
Gastroenterology; 2018 Oct; 155(4):1233-1249.e22. PubMed ID: 30009820
[TBL] [Abstract][Full Text] [Related]
17. Preclinical assesement of survivin and XIAP as prognostic biomarkers and therapeutic targets in gastroenteropancreatic neuroendocrine neoplasia.
Dizdar L; Oesterwind KA; Riemer JC; Werner TA; Mersch S; Möhlendick B; Schütte SC; Verde PE; Raba K; Topp SA; Stoecklein NH; Esposito I; Knoefel WT; Krieg A
Oncotarget; 2017 Jan; 8(5):8369-8382. PubMed ID: 28039474
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathological characteristics of RHOA mutations in a Central European gastric cancer cohort.
Röcken C; Behrens HM; Böger C; Krüger S
J Clin Pathol; 2016 Jan; 69(1):70-5. PubMed ID: 26251521
[TBL] [Abstract][Full Text] [Related]
19. Reversal of the malignant phenotype of gastric cancer cells by inhibition of RhoA expression and activity.
Liu N; Bi F; Pan Y; Sun L; Xue Y; Shi Y; Yao X; Zheng Y; Fan D
Clin Cancer Res; 2004 Sep; 10(18 Pt 1):6239-47. PubMed ID: 15448013
[TBL] [Abstract][Full Text] [Related]
20. Bufalin inhibits peritoneal dissemination of gastric cancer through endothelial nitric oxide synthase-mitogen-activated protein kinases signaling pathway.
Zou D; Song J; Deng M; Ma Y; Yang C; Liu J; Wang S; Wen Z; Tang Y; Qu X; Zhang Y
FASEB J; 2021 May; 35(5):e21601. PubMed ID: 33913201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
